Grants Awarded

  • All
  • LCH
  • Rare Histiocytic Disorders and Other Topics
  • RDD

MEK Inhibition in the Therapy of Histiocytic Neoplasms

Principal Investigator Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center New York, New York USA Date of…

Read More

Identification of Molecular Mechanisms Underlying Defective Cytotoxic Lymphocyte Function in Chediak-Higashi Syndrome, a Histiocytic Lysosomal Storage Disorder with Immunodeficiency

Principal Investigator Konrad Krzewski, PhD National Institute of Allergy and Infectious Diseases, National Institutes of Health Rockville,…

Read More

Genetic Dissection of the Exocytic Machinery in Cytotoxic Lymphocytes

Principal Investigator Matthias Voss, PhD Karolinska Institutet Stockholm, Sweden   Date of Award December 2015 Amount of…

Read More

Deciphering the Underlying Molecular Defects in CTL and NK Cell Cytotoxicity in FHL Patients

Principal Investigator Claudio Giraudo, PhD The Children’s Hospital of Philadelphia University of Pennsylvania Philadelphia, Pennsylvania USA Date…

Read More

The Interplay of NOTCH and MAPK Pathway in LCH

Principal Investigator Raphaela Schwentner, MSc, PhD Children’s Cancer Research Institute Vienna, Austria   Date of Award December…

Read More

LCH-IV Clinical Trial – Stratum I Patient Registration Reimbursement for North American Institutions

Principal Investigator Carlos Rodriguez-Galindo, MD St. Jude Children’s Research Hospital Memphis, Tennessee USA   Date of Award…

Read More